The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
The researchers’ goal was to determine whether occipital nerve stimulation could serve as an effective treatment for patients with medically intractable chronic cluster headache.
A team of investigators in Australia sought to identify the frequency of cervical musculoskeletal dysfunction in patients with neck pain during migraine.
